Key Events This Week
Feb 9: Downgrade to Sell by MarketsMOJO announced
Feb 13: Q3 FY26 results reveal revenue decline but stable margins
Feb 13: Week closes at Rs.115.20 (-1.66%)

Smruthi Organics Q3 FY26: Revenue Decline Weighs on Performance Despite Margin Resilience
2026-02-13 13:53:49Smruthi Organics Ltd., a micro-cap pharmaceuticals and biotechnology company with a market capitalisation of ₹137.00 crores, reported a challenging third quarter for FY2026, with net profit declining 32.04% quarter-on-quarter to ₹1.40 crores from ₹2.06 crores in Q2 FY26. On a year-on-year basis, the company managed a modest 5.41% decline from ₹1.48 crores in Q3 FY25. The stock traded at ₹117.00 on February 13, 2026, down 0.85% from the previous close, reflecting investor concerns over the sequential revenue contraction that has pressured profitability.
Read full news article
Smruthi Organics Ltd Downgraded to Sell Amid Technical Weakness and Long-Term Underperformance
2026-02-09 08:15:00Smruthi Organics Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 6 February 2026. This revision reflects a combination of deteriorating technical indicators, subdued long-term financial trends, and valuation concerns despite some recent positive quarterly performance.
Read full news articleWhen is the next results date for Smruthi Organics Ltd?
2026-02-06 23:18:28The next results date for Smruthi Organics Ltd is scheduled for 13 February 2026....
Read full news article
Smruthi Organics Ltd Upgraded to Hold: A Detailed Analysis of Quality, Valuation, Financial Trend and Technicals
2026-02-02 08:32:52Smruthi Organics Ltd has seen its investment rating upgraded from Sell to Hold as of 1 February 2026, reflecting a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality. This recalibration comes amid a backdrop of mixed long-term performance but recent positive financial results and a shift in technical momentum, prompting a reassessment of the stock’s outlook within the Pharmaceuticals & Biotechnology sector.
Read full news article
Smruthi Organics Ltd is Rated Sell
2026-01-28 10:10:35Smruthi Organics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 January 2026, providing investors with an up-to-date perspective on its performance and outlook.
Read full news article
Smruthi Organics Ltd Forms Death Cross, Signalling Potential Bearish Trend
2026-01-06 18:01:49Smruthi Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting deteriorating momentum and raising concerns about the stock’s long-term strength.
Read full news article
Smruthi Organics Ltd is Rated Hold
2026-01-05 10:10:04Smruthi Organics Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 January 2026, providing investors with the latest insights into its performance and outlook.
Read full news article





